Rheumatic And Musculoskeletal Diseases

More than half of a cohort of patients with rheumatic or musculoskeletal diseases reported experiencing some post-traumatic stress outcomes during the COVID-19 pandemic, according to data presented at the EULAR 2022 Congress.

Individuals with rheumatic, autoimmune or musculoskeletal diseases are not at increased risk of acquiring SARS-CoV-2, according to one of the authors of the EULAR COVID-19 recommendations who addressed the EULAR 2021 Congress.

Although the risk for severe COVID-19 outcomes in patients with rheumatic and musculoskeletal disease has lowered, it is nonetheless still significant, according to data published in The Lancet Rheumatology.